Department of Obstetrics and Gynecology, Institute of Women's Life Medical Science, Yonsei University Health System, Seoul 03722, Korea.
Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul 03722, Korea.
Int J Mol Sci. 2021 Apr 19;22(8):4237. doi: 10.3390/ijms22084237.
The abnormal development or disruption of the lymphatic vasculature has been implicated in metabolic and hypertensive diseases. Recent evidence suggests that the offspring exposed to preeclampsia (PE) in utero are at higher risk of long-term health problems, such as cardiovascular and metabolic diseases in adulthood, owing to in utero fetal programming. We aimed to investigate lymphangiogenic activities in the lymphatic endothelial progenitor cells (LEPCs) of the offspring of PE. Human umbilical cord blood LEPCs from pregnant women with severe PE ( = 10) and gestationally matched normal pregnancies ( = 10) were purified with anti-vascular endothelial growth factor receptor 3 (VEGFR3)/podoplanin/CD11b microbeads using a magnetic cell sorter device. LEPCs from PE displayed significantly delayed differentiation and reduced formation of lymphatic endothelial cell (LEC) colonies compared with the LEPCs from normal pregnancies. LECs differentiated from PE-derived LEPCs exhibited decreased tube formation, migration, proliferation, adhesion, wound healing, and 3D-sprouting activities as well as increased lymphatic permeability through the disorganization of VE-cadherin junctions, compared with the normal pregnancy-derived LECs. In vivo, LEPCs from PE showed significantly reduced lymphatic vessel formation compared to the LEPCs of the normal pregnancy. Gene expression analysis revealed that compared to the normal pregnancy-derived LECs, the PE-derived LECs showed a significant decrease in the expression of pro-lymphangiogenic genes (, , , , , , , , and ). Collectively, our findings demonstrate, for the first time, that LEPCs from PE have reduced lymphangiogenic activities in vitro and in vivo and show the decreased expression of pro-lymphangiogenic genes. This study opens a new avenue for investigation of the molecular mechanism of LEPC differentiation and lymphangiogenesis in the offspring of PE and subsequently may impact the treatment of long-term health problems such as cardiovascular and metabolic disorders of offspring with abnormal development of lymphatic vasculature.
淋巴管系统的异常发育或破坏与代谢和高血压疾病有关。最近的证据表明,在子宫内暴露于子痫前期(PE)的胎儿在成年后患长期健康问题(如心血管和代谢疾病)的风险更高,这是由于宫内胎儿编程。我们旨在研究 PE 孕妇脐带血中淋巴管内皮祖细胞(LEPC)的淋巴管生成活性。使用磁性细胞分选器设备,用抗血管内皮生长因子受体 3(VEGFR3)/ podoplanin/ CD11b 微珠从患有严重 PE(n = 10)和妊娠期匹配正常妊娠的孕妇的脐血中纯化 LEPC。与来自正常妊娠的 LEPC 相比,PE 来源的 LEPC 的分化明显延迟,并且形成淋巴管内皮细胞(LEC)集落的能力降低。与正常妊娠衍生的 LEC 相比,从 PE 衍生的 LEPC 分化而来的 LEC 的管形成、迁移、增殖、黏附、伤口愈合和 3D 发芽活性降低,并且通过 VE-钙粘蛋白连接的解体导致淋巴管通透性增加。在体内,与正常妊娠衍生的 LEPC 相比,PE 衍生的 LEPC 的淋巴管形成明显减少。基因表达分析显示,与正常妊娠衍生的 LEC 相比,PE 衍生的 LEC 中促淋巴管生成基因(、、、、、、、、和)的表达显著降低。总之,我们的研究结果首次表明,PE 患者的 LEPC 体外和体内的淋巴管生成活性降低,并显示促淋巴管生成基因的表达降低。这项研究为研究 PE 胎儿 LEPC 分化和淋巴管生成的分子机制开辟了新途径,随后可能会影响治疗具有异常淋巴管发育的后代的长期健康问题,如心血管和代谢障碍。